Pierre Alain Boulanger

Title: Pierre Alain Boulanger: Innovator in Modified Virus Technology

Introduction

Pierre Alain Boulanger is a notable inventor based in Lyon, France. He has made significant contributions to the field of biotechnology, particularly in the development of modified viruses for therapeutic applications. His innovative work focuses on the treatment of tumors and cancerous cells, showcasing the potential of his inventions in medical science.

Latest Patents

Boulanger holds a patent for a modified virus comprising one or more non-native polypeptides. This patent describes a modified virus that includes one or more non-native polypeptides, which can be utilized in therapy, especially for treating tumors or other cancerous cells. The polypeptides feature one or more framework moieties, each containing binding moieties capable of being expressed in the cytoplasm and nucleus of a mammalian host cell. This conformation is maintained even in the absence of a ligand for the binding moieties, allowing for subsequent binding with the ligand. Additionally, the polypeptide can transport through the nuclear membrane, and the modified virus has an altered tropism conferred by the binding moieties. Boulanger's patent represents a significant advancement in the field of cancer treatment.

Career Highlights

Pierre Alain Boulanger is associated with Got-A-Gene Ab, where he continues to push the boundaries of genetic research and therapeutic applications. His work has garnered attention for its innovative approach to utilizing modified viruses in medical treatments.

Collaborations

Boulanger has collaborated with notable professionals in his field, including Leif Lindholm and Anna Karin Nord. These collaborations have contributed to the advancement of his research and the development of new therapeutic strategies.

Conclusion

Pierre Alain Boulanger's contributions to the field of biotechnology, particularly through his patent on modified viruses, highlight his role as an innovator in cancer treatment. His work continues to inspire advancements in medical science and therapeutic applications.